Cargando…
Inhibition of mTOR Pathway by Rapamycin Reduces Brain Damage in Rats Subjected to Transient Forebrain Ischemia
The aims of this study are to clarify the role of mTOR in mediating cerebral ischemic brain damage and the effects of rapamycin on ischemic outcomes. Ten minutes of forebrain ischemia was induced in rats, and their brains were sampled after 3 h, 16 h, and 7 days reperfusion for histology, immunohist...
Autores principales: | Yang, Xiao, Hei, Changhun, Liu, Ping, Song, Yaozu, Thomas, Taylor, Tshimanga, Sylvie, Wang, Feng, Niu, Jianguo, Sun, Tao, Li, P. Andy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672000/ https://www.ncbi.nlm.nih.gov/pubmed/26681922 http://dx.doi.org/10.7150/ijbs.12930 |
Ejemplares similares
-
Rapamycin Reduced Ischemic Brain Damage in Diabetic Animals Is Associated with Suppressions of mTOR and ERK1/2 Signaling
por: Liu, Ping, et al.
Publicado: (2016) -
Effects of mTOR on Neurological Deficits after Transient Global Ischemia
por: Xing, Jihong, et al.
Publicado: (2017) -
Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
por: Murray, James T., et al.
Publicado: (2018) -
Unbiased evaluation of rapamycin's specificity as an mTOR inhibitor
por: Artoni, Filippo, et al.
Publicado: (2023) -
Inhibition of mTOR signaling Confers Protection against Cerebral Ischemic Injury in Acute Hyperglycemic Rats
por: Hei, Changchun, et al.
Publicado: (2017)